These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 21872277)

  • 1. Thirty- and ninety-day outcomes after sublobar resection with and without brachytherapy for non-small cell lung cancer: results from a multicenter phase III study.
    Fernando HC; Landreneau RJ; Mandrekar SJ; Hillman SL; Nichols FC; Meyers B; DiPetrillo TA; Heron DE; Jones DR; Daly BD; Starnes SL; Tan A; Putnam JB
    J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1143-51. PubMed ID: 21872277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of adjuvant brachytherapy with sublobar resection on pulmonary function and dyspnea in high-risk patients with operable disease: preliminary results from the American College of Surgeons Oncology Group Z4032 trial.
    Fernando HC; Landreneau RJ; Mandrekar SJ; Hillman SL; Nichols FC; Meyers B; DiPetrillo TA; Heron D; Jones DR; Daly BD; Starnes SL; Hatter JE; Putnam JB
    J Thorac Cardiovasc Surg; 2011 Sep; 142(3):554-62. PubMed ID: 21724195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Sublobar Resection on Pulmonary Function: Long-Term Results from American College of Surgeons Oncology Group Z4032 (Alliance).
    Kent MS; Mandrekar SJ; Landreneau R; Nichols F; DiPetrillo TA; Meyers B; Heron DE; Jones DR; Tan AD; Starnes S; Putnam JB; Fernando HC
    Ann Thorac Surg; 2016 Jul; 102(1):230-8. PubMed ID: 27101728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of longitudinal quality-of-life data in high-risk operable patients with lung cancer: results from the ACOSOG Z4032 (Alliance) multicenter randomized trial.
    Fernando HC; Landreneau RJ; Mandrekar SJ; Nichols FC; DiPetrillo TA; Meyers BF; Heron DE; Hillman SL; Jones DR; Starnes SL; Tan AD; Daly BD; Putnam JB;
    J Thorac Cardiovasc Surg; 2015 Mar; 149(3):718-25; discussion 725-6. PubMed ID: 25500100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The National Surgical Quality Improvement Program risk calculator does not adequately stratify risk for patients with clinical stage I non-small cell lung cancer.
    Samson P; Robinson CG; Bradley J; Lee A; Broderick S; Kreisel D; Krupnick AS; Patterson GA; Puri V; Meyers BF; Crabtree T
    J Thorac Cardiovasc Surg; 2016 Mar; 151(3):697-705.e1. PubMed ID: 26410001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with preserved pulmonary function in non-small-cell lung cancer patients after video-assisted thoracic surgery.
    Kim SJ; Ahn S; Lee YJ; Park JS; Cho YJ; Cho S; Yoon HI; Kim K; Lee JH; Jheon S; Lee CT
    Eur J Cardiothorac Surg; 2016 Apr; 49(4):1084-90. PubMed ID: 26374869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marginal pulmonary function should not preclude lobectomy in selected patients with non-small cell lung cancer.
    Taylor MD; LaPar DJ; Isbell JM; Kozower BD; Lau CL; Jones DR
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):738-44; Discussion 744-6. PubMed ID: 24252944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parenchymal preserving anatomic resections result in less pulmonary function loss in patients with Stage I non-small cell lung cancer.
    Macke RA; Schuchert MJ; Odell DD; Wilson DO; Luketich JD; Landreneau RJ
    J Cardiothorac Surg; 2015 Apr; 10():49. PubMed ID: 25888465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes After Surgery in High-Risk Patients With Early Stage Lung Cancer.
    Sancheti MS; Melvan JN; Medbery RL; Fernandez FG; Gillespie TW; Li Q; Binongo JN; Pickens A; Force SD
    Ann Thorac Surg; 2016 Mar; 101(3):1043-50; Discussion 1051. PubMed ID: 26572255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Segmentectomy versus wedge resection for non-small cell lung cancer in high-risk operable patients.
    Kent M; Landreneau R; Mandrekar S; Hillman S; Nichols F; Jones D; Starnes S; Tan A; Putnam J; Meyers B; Daly B; Fernando HC
    Ann Thorac Surg; 2013 Nov; 96(5):1747-54; discussion 1754-5. PubMed ID: 23998400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system.
    Carr SR; Schuchert MJ; Pennathur A; Wilson DO; Siegfried JM; Luketich JD; Landreneau RJ
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):390-7. PubMed ID: 22169444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do the surgical results in the National Lung Screening Trial reflect modern thoracic surgical practice?
    Kamel MK; Lee B; Harrison S; Port JL; Pua B; Altorki NK; Stiles BM
    J Thorac Cardiovasc Surg; 2019 May; 157(5):2038-2046.e1. PubMed ID: 31288364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Risk Score to Assist Selecting Lobectomy Versus Sublobar Resection for Early Stage Non-Small Cell Lung Cancer.
    Gulack BC; Yang CJ; Speicher PJ; Yerokun BA; Tong BC; Onaitis MW; D'Amico TA; Harpole DH; Hartwig MG; Berry MF
    Ann Thorac Surg; 2016 Dec; 102(6):1814-1820. PubMed ID: 27592602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancer.
    Fernando HC; Landreneau RJ; Mandrekar SJ; Nichols FC; Hillman SL; Heron DE; Meyers BF; DiPetrillo TA; Jones DR; Starnes SL; Tan AD; Daly BD; Putnam JB
    J Clin Oncol; 2014 Aug; 32(23):2456-62. PubMed ID: 24982457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections.
    Sienel W; Dango S; Kirschbaum A; Cucuruz B; Hörth W; Stremmel C; Passlick B
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):728-34. PubMed ID: 18261918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lobectomy for Non-Small Cell Lung Cancer by Video-Assisted Thoracic Surgery: Effects of Cumulative Institutional Experience on Adequacy of Lymphadenectomy.
    Lee PC; Kamel M; Nasar A; Ghaly G; Port JL; Paul S; Stiles BM; Andrews WG; Altorki NK
    Ann Thorac Surg; 2016 Mar; 101(3):1116-22. PubMed ID: 26654728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503).
    Altorki NK; Wang X; Wigle D; Gu L; Darling G; Ashrafi AS; Landrenau R; Miller D; Liberman M; Jones DR; Keenan R; Conti M; Wright G; Veit LJ; Ramalingam SS; Kamel M; Pass HI; Mitchell JD; Stinchcombe T; Vokes E; Kohman LJ
    Lancet Respir Med; 2018 Dec; 6(12):915-924. PubMed ID: 30442588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of preoperative body mass index on respiratory complications after pneumonectomy for non-small-cell lung cancer. Results from a series of 154 consecutive standard pneumonectomies.
    Petrella F; Radice D; Borri A; Galetta D; Gasparri R; Solli P; Veronesi G; Spaggiari L
    Eur J Cardiothorac Surg; 2011 May; 39(5):738-44. PubMed ID: 20952203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublobar resection with brachytherapy versus lobectomy for stage Ib nonsmall cell lung cancer.
    Birdas TJ; Koehler RP; Colonias A; Trombetta M; Maley RH; Landreneau RJ; Keenan RJ
    Ann Thorac Surg; 2006 Feb; 81(2):434-8; discussion 438-9. PubMed ID: 16427827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublobar versus lobar resection: current status.
    Narsule CK; Ebright MI; Fernando HC
    Cancer J; 2011; 17(1):23-7. PubMed ID: 21263263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.